Skip to content

Randomized controlled study on clinical application value of composite bone graft fusion materials

Randomized controlled study on clinical application value of composite bone graft fusion materials

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300073231
Enrollment
Unknown
Registered
2023-07-04
Start date
2023-07-01
Completion date
Unknown
Last updated
2023-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar spinal stenosis, lumbar disc herniation

Interventions

Autogenous bone grafting bone fusion group :Interbody fusion was performed by mixing autogenous vertebral laminae spinous bone granule with domestic vancomycin
Test group:composite bone graft fusion materials

Sponsors

Department of Spinal Surgery, Shenzhen Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: ?CT, MRI and other imaging tests confirmed LSS or LDH; ? The main complaint is sciatica, which may be accompanied by lower extremity muscle weakness, tendon reflex abnormality, sensory disturbance, positive straight leg elevation test, etc. ? No definite contraindications for surgery; (4) Patients and their families give informed consent and sign informed consent.

Exclusion criteria

Exclusion criteria: ? Vertebral tumor or infection of the operative area of the vertebral body; ? History of lumbar surgery; ? Recently received invasive spinal treatment, such as intraspinal injection of corticosteroids, antibiotics, etc.;

Design outcomes

Primary

MeasureTime frame
Lumbar interbody fusion rate;

Secondary

MeasureTime frame
Deep infection rate after lumbar surgery;

Countries

China

Contacts

Public ContactZeng Tenghui

Shenzhen Second People's Hospital

1697988399@qq.com+86 189 2349 6999

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026